Bottom line
How much do FHLC and GGHCX overlap?
54% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 48.7% of FHLC's assets and 44.0% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 82), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and GGHCX have in common
| Holding | % of FHLC | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 10.59% | 10.59% |
| Johnson & Johnson | 8.93% | 6.76% | 6.76% |
| AbbVie Inc | 6.42% | 4.03% | 4.03% |
| UnitedHealth Group Inc | 5.44% | 6.17% | 5.44% |
| Merck & Co Inc | 4.66% | 4.59% | 4.59% |
| Thermo Fisher Scientific Inc | 3.09% | 1.55% | 1.55% |
| Gilead Sciences Inc | 2.34% | 3.63% | 2.34% |
| CVS Health Corp | 1.92% | 2.52% | 1.92% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.01% | 1.76% |
| Cardinal Health Inc | 0.78% | 2.10% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Pfizer Inc — 2.06%
- Bristol-Myers Squibb Co — 1.93%
- Intuitive Surgical Inc — 1.82%
- Danaher Corp — 1.80%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- McKesson Corp — 1.52%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- Boston Scientific Corp — 1.00%
- HCA Healthcare Inc — 0.91%
- Cencora Inc — 0.83%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | FHLC | GGHCX |
|---|---|---|
| Stocks | 99.7% | 97.5% |
| Cash & short-term funds | 0.2% | 8.8% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FHLC | GGHCX |
|---|---|---|
| US | 96.5% | 93.5% |
| NL | 0.1% | 3.4% |
| GB | 0.5% | 3.1% |
| CH | 0.1% | 2.7% |
| IE | 2.2% | 0.6% |
| BE | — | 1.2% |
| DK | — | 1.1% |
| IL | — | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FHLC and GGHCX overlap?
What stocks do FHLC and GGHCX have in common?
Should I own both FHLC and GGHCX?
Which holds more stocks, FHLC or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.